Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04244552
Title First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Atreca, Inc.

lung non-small cell carcinoma

breast cancer

acral lentiginous melanoma

colorectal cancer

ovarian cancer



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.